A Rockville immunotherapy company struck an $8 million deal to take back ownership of the drug candidates it’s been licensing ...

Canadian Cancer Society reports draw attention to the disease’s financial burden on patients, which includes the toll of ...

A research team affiliated with UNIST has unveiled an innovative technology to eliminate drug-resistant cancer cells using ...

A new computational tool could help researchers identify promising drug combinations for treating cancer, according to a new ...

IIT Madras launches cancer genome database to transform cancer research in India, aiming to identify biomarkers and ...

The shortage of generic chemotherapy drugs cisplatin and carboplatin that began in early 2023 did not increase short-term ...

A national study seeking more effective treatment for deadly metaplastic breast cancer has identified two inhibitor drugs with the potential to interrupt disease progression.

A new nasal delivery method for amifostine could protect healthy tissue during pancreatic cancer radiation therapy, ...

Visakhapatnam: Drug repurposing is emerging as a promising strategy for tackling drug-resistant and metastatic cancers.

The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...

A new case report details a novel genetic mutation linked to drug resistance in a non-small cell lung cancer patient ...

Ac-SSO110 has now received FDA orphan drug designation and investigational new drug application clearance for the treatment ...